Selected Publications

Tanyi JL, Haas AR, Morgan MA, Aggarwal C, O'Hara MH, Lacey SF, Young RM, Sheppard NC, Albelda S, June CH.: Comparing the autologous T cells bearing fully-humanized chimeric antigen receptors (M5) to non-humanized CAR T (SS1) for targeting mesothelin in mesothelin-expressing cancers. Society of Pelvic Surgeon Annual Meeting - Oral Presentation : 2022.

Aznar AM, Good CR, Kuramitsu S, Samareh P, Agarwal S, Donahue G, Ishiyama K, Wellhausen N, Rennels AK, Ma Y, Tian L, Guedan S, Alexander KA, Zhang Z, Rommel PC, Singh N, Glastad KM, Richardson MW, Watanabe K, Tanyi JL, O’Hara MH, Ruella M, Lacey SF, Moon EK, Schuster SJ, Albelda SM, Lanier LL, Young RM, Berger SL, June CH.: Mechanisms of CAR T cell dysfunction and identification of transcription factors that drive the exhaustion phenotype AACR Annual Meeting - Oral Presentation : 2022.

Tanyi JL, Haas AR, Aggarwal C, O'Hara MH, Lacey SF, Golden R, Hwang WT, Young RM, Sheppard NC, Albelda S, June CH.: Phase I study of autologous T cells bearing fully-humanized chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers SGO Annual Meeting - Poster : 2022.

Mastroyannis SA, Chen A, Ko E, Facciabene A, Tanyi JL.: Antibiotic exposure around first-line chemotherapy and survival in ovarian cancer SGO Annual Meeting - Poster : 2022.

Jiang J, Yuan J, Hu Z, Zhang Y, Zhang T, Xu M, Long M, Fan Y, Tanyi JL, Montone KT, Tavana O, Vonderheide RH, Chan HM, Hu X, Zhang L.: Systematic illumination of druggable genes in cancer genomes. Cell Rep. : 38(8):110400. doi: 10.1016/j.celrep.2022.110400,2022.

Jiang J, Yuan J, Hu Z, Xu M, Zhang Y, Long M, Fan Y, Montone KT, Tanyi JL, Tavana O, Chan HM, Zhang L, Hu X: Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets. Cancer Res : 82(1):46-59. doi: 10.1158/0008-5472.CAN-20-3458,2022.

Good CR, Aznar MA, Kuramitsu S, Samareh P, Agarwal S, Donahue G, Ishiyama K, Wellhausen N, Rennels AK, Ma Y, Tian L, Guedan S, Alexander KA, Zhang Z, Rommel PC, Singh N, Glastad KM, Richardson MW, Watanabe K, Tanyi JL, O'Hara MH, Ruella M, Lacey SF, Moon EK, Schuster SJ, Albelda SM, Lanier LL, Young RM, Berger SL, June CH.: An NK-like CAR T cell transition in CAR T cell dysfunction. Cell : 184(25):6081-6100.e26. doi: 10.1016/j.cell.2021.11.016,2021.

Hu Z, Yuan J, Long M, Jiang J, Zhang Y, Zhang T, Xu M, Fan Y, Tanyi JL, Montone KT, Tavana O, Chan HM, Hu X, Vonderheide RH, Zhang L.: The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets. Nat Cancer. : 2(12):1406-1422. doi: 10.1038/s43018-021-00282-w. ,2021.

Duraiswamy J, Turrini R, Minasyan A, Barras D, Crespo I, Grimm AJ, Casado J, Genolet R, Benedetti F, Wicky A, Ioannidou K, Castro W, Neal C, Moriot A, Renaud-Tissot S, Anstett V, Fahr N, Tanyi JL, Eiva MA, Jacobson CA, Montone KT, Westergaard MCW, Svane IM, Kandalaft LE, Delorenzi M, Sorger PK, Färkkilä A, Michielin O, Zoete V, Carmona SJ, Foukas PG, Powell DJ Jr, Rusakiewicz S, Doucey MA, Dangaj Laniti D, Coukos G: Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation. Cancer Cell : 39(12):1623-1642.e20. doi: 10.1016/j.ccell.2021,2021.

Shah PD, Wethington SL, Pagan C, Latif N, Tanyi J, Martin LP, Morgan M, Burger RA, Haggerty A, Zarrin H, Rodriguez D, Domchek S, Drapkin R, Shih IM, Smith SA, Dean E, Gaillard S, Armstrong D, Torigian DA, Hwang WT, Giuntoli R, Simpkins F: Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer. Gynecol Oncol. : 163(2):246-253. doi: 10.1016/j.ygyno.2021.08.024. ,2021.

Academic Contact Information

Department of Obstetrics and Gynecology
Jordan Center for Gynecologic Cancer at Penn
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard, 3 West
Philadelphia, PA 19104
Phone: 215-662-3318
Patient appointments: 800-789-7366